1. Immunoreactivity and in-vitro effect on human sperm-egg binding of antibodies against peptides corresponding to bonnet monkey zona pellucida-3 glycoprotein.
- Author
-
Afzalpurkar A, Shibahara H, Hasegawa A, Koyama K, and Gupta SK
- Subjects
- Amino Acid Sequence, Animals, Diphtheria Toxoid immunology, Egg Proteins chemistry, Female, Fluorescent Antibody Technique, Indirect, Humans, Immune Sera immunology, Immunization, Macaca radiata immunology, Male, Membrane Glycoproteins chemistry, Molecular Sequence Data, Vaccines, Zona Pellucida Glycoproteins, Contraception, Immunologic, Egg Proteins immunology, Immune Sera pharmacology, Membrane Glycoproteins immunology, Receptors, Cell Surface, Sperm-Ovum Interactions drug effects, Zona Pellucida immunology
- Abstract
The following synthetic peptides were made as immunogens for development of a zona-based contraceptive vaccine: P1, KQPFWLLQGGASRAETSVQPVLVE [amino acids (aa) 23-45 with an additional K at the N-terminus]; P2, FSEEKLVFSLRLMEENC (aa 164-179 with an additional C at the C-terminus and T170 replaced by V); and P3, CSFSKSSNSWFPVEGPADICQCC (aa 300-322). The aa are numbered on the basis of bonnet monkey ZP3 precursor protein. Antibodies against an additional peptide P4, KGDCGTPSHSRRQPHVVSQWSRSA (aa 324-347), significantly inhibits human sperm-oocyte binding. In addition, antibodies against cocktail of peptide-diphtheria toxoid conjugates also significantly inhibit the binding of spermatozoa to zona pellucida in a hemizona assay. These results will further help in the design of an immunocontraceptive vaccine based upon synthetic peptides corresponding to ZP3.
- Published
- 1997
- Full Text
- View/download PDF